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of the medication and reduce the adverse effects. The strict control of the pain can modify the staging, understating, of the
esophagitis.
http://dx.doi.org/10.1016/j.rpor.2013.03.584
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Purpose. To evaluate and control breakthrough pain (BP) episodes in advanced cancer patients undergoing radiotherapy during
proceedings and maneuvers necessary to receive treatment, and assess the ability of Fentanyl pectin nasal citrate (FPNC) to
control these episodes.
Patients and methods. Seventeenpatientswith severe BP associated to routine radiotherapyprocedures andmaneuvers (simulation,
imagining acquisition, treatment delivery with external or brachytherapy), were selected to receive FPNC for pain relief. Most
patients (15/17) suffered from bone metastases and showed a low Karnovsky performance status (30–70%). BP intensity was
evaluated by Visual Analog Scale (VAS) before and after the procedures that triggered it. All patients described a very high VAS
value (9–10) related with the speciﬁc procedure. All patients were already receiving an opioid basal treatment at total dose
equivalent to 40–80mg morphine. BP was treated before the speciﬁc procedure with a dose of 100–400g of FPNC. Data related
to tolerance, pain relief, onset of the relief and efﬁcient dose to allow the procedure were collected.
Results. In all patients, BP score was reduced at least to 50% after 13min (5–30min) of fentanyl administration. Pain relief started
after 7min (5–15min) and the duration of the effect permitted the normal procedure development. All patients reported pain
control with a dose of 200g of FPNC except one patient who required progressive doses till 600g. Seven patients reported
minor undesirable effects related to the FPNC administration.
Conclusions. Procedures and maneuvers necessary to apply radiotherapy in ACP may provoke in some of them severe BP episodes,
so a strong and rapid analgesic is needed. FPNC offers a rapid absorption and pain relief, being particularly efﬁcient and well
accepted in these patients. This relief allows the completion of necessary procedures to administrate treatment without adding
unnecessary suffering to patients.
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Introduction.Malnutrition andweight loss are common inpatientswith cancer (from8% to 87%) and can lead tonegative outcomes.
Cachexia and anorexia are their main causes, associated with stage and site – especially aerodigestive tumors. Radiotherapy
(RT) can produce an extra deterioration. Nevertheless, almost half of patients with RT receive nutritional assessment. Between
late 2012 – early 2013, we have developed a procedure whose objective is to implement a systematic method, by which make
individualized decisions, trying to solve nutrition problems and improve outcomes.
Purpose. To provide a description of the process and communicate data and reﬂections.
Methods and materials. The procedure, inspired in the Nutrition Care Process, consists of three steps: (a) nutritional assessment,
(b) intervention and (c) monitoring. We apply the Malnutrition Screening Tool (MST) and Patient-Generated Subjective Global
Assessment (PG-SGA) questionnaires to identify the risk and implement a plan. QLQ-c30 form to measure Quality of Life (QoL).
Nutrition intervention ranges from counseling (speciﬁc leaﬂets) to providing supplements, medications, tube feeding or referring
to other specialists. Monitoring includes follow-up and revising strategies. Nutritional status is re-assessed every 3 weeks after
starting RT (weekly in patients at higher risk), at the end and three months later.
Results and reﬂections. At 2 months, 25 patients have been included. Low risk patients maintained or improved overall QOL. Only
2 patients were classiﬁed as high risk. There are no interruptions because of malnutirition. This procedure has been planed to
be dynamically carried out, but we ﬁnd some difﬁculties: there can be more clinical problems, it takes long or collaboration with
other professionals may be difﬁcult.
Conclusions. Malnutrition is common in RT. Suitable screening tools and individualized intervention positively may inﬂuence
nutritional status, prognosis and QoL. Our workﬂow allows us to diagnose, treat and monitor patients with cancer and nutritional
needs.
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